Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.38 |
| ▸ | CACNA1H | O95180 | 4/20 | 0.38 |
| ▸ | CACNA1I | Q9P0X4 | 4/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13721165 | 0.86 | KMT2A (0.48) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL16155964 | 0.84 | AKR1B1 (0.45) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13720252 | 0.83 | KDM4E (0.41) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13721379 | 0.83 | MEN1 (0.46) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13721316 | 0.83 | KDM4E (0.45) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13720819 | 0.82 | KDM4E (0.45) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13858401 | 0.81 | KDM4E (0.45) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13721003 | 0.80 | KDM4E (0.49) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13720425 | 0.76 | MAPK8 (0.41) | KDM4EHPGDALDH1A1MEN1KMT2A | |
| SCHEMBL13721378 | 0.76 | HPGD (0.47) | KDM4EHPGDALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120289500-A1 | POTASSIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2012-11-15 | — | — | US | claimed |
| US-8859549-B2 | Potassium channel modulators | ABBVIE, INC. (US) | 2014-10-14 | — | — | US | disclosed |
| US-20120289500-A1 | POTASSIUM CHANNEL MODULATORS | ABBOTT LABORATORIES (US) | 2012-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120289500-A1 | POTASSIUM CHANNEL MODULATORS | KCNQ1, KCNQ2, KCNJ2 | KDM4E 751/4885HPGD 1562/4885ALDH1A1 743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.